Participants:0–17 years · 18–64 years · Healthy volunteers
Substances:GROUP B STREPTOCOCCUS CAPSULAR POLYSACCHARIDE IB CONJUGATED TO DIPHTHERIA TOXIN CRM197

Contact Research Centre

Still's disease

Recruiting

Registered drugNo placebo

A Study of MAS825 in Children and Adults with Still's Disease to Test How Well It Works and How Safe It Is

Registered drugNo placebo

Spain

Participants:0–17 years · 18–64 years · 65+ years
Substances:Human Igg1 Monoclonal Antibody Against Human Il-1 Beta And Human Il-18

Contact Research Centre

Chronic graft versus host disease

Recruiting

InvestigationalNo placebo

Study of Axatilimab compared to standard therapy in children with chronic graft-versus-host disease who have previously received at least 2 treatments

InvestigationalNo placebo

Spain

Participants:0–17 years
Substances:Axatilimab

Contact Research Centre

Spinal muscular atrophy

Recruiting

InvestigationalNo placebo

Study of Apitegromab Treatment in Children Under 2 Years Old with Spinal Muscular Atrophy (SMA)

InvestigationalNo placebo

Spain

Participants:0–17 years
Substances:Apitegromab

Contact Research Centre

PIK3CA related overgrowth spectrum

Recruiting

InvestigationalNo placebo

Study of alpelisib in children and adults with PIK3CA-Related Overgrowth Spectrum (PROS)

InvestigationalNo placebo

Spain

Participants:0–17 years · 18–64 years · 65+ years
Substances:Alpelisib

Contact Research Centre

Alopecia areata

Recruiting

Investigational

Long-term safety and effectiveness study of ritlecitinib in children with severe alopecia areata who completed previous trials B7981027 or B7981031

Investigational

Spain

Participants:0–17 years

Contact Research Centre

Epileptic encephalopathy

Recruiting

InvestigationalNo placebo

Study of intrathecal S230815 to evaluate safety and effectiveness in children with KCNT1-related Developmental and Epileptic Encephalopathy

InvestigationalNo placebo

Spain

Participants:0–17 years
Substances:S230815-2

Contact Research Centre

Chronic graft versus host disease

Recruiting

InvestigationalNo placebo

Study of belumosudil in children aged 1 to 18 years with moderate to severe chronic graft versus host disease requiring systemic treatment

InvestigationalNo placebo

Spain

Participants:0–17 years · 18–64 years
Substances:Belumosudil Mesilate

Contact Research Centre

B-cell lymphoma recurrent+1

Recruiting

Registered drugNo placebo

Study of drug combination therapy in children and adolescents with relapsed or refractory B-cell non-Hodgkin lymphoma using odronextamab, loncastuximab tesirine and rituximab

Registered drugNo placebo

Spain

Participants:0–17 years · 18–64 years
Substances:Carboplatin

Contact Research Centre

Immune thrombocytopenia

Recruiting

Investigational

Study of efgartigimod given by IV infusion in adolescents aged 12-17 years with chronic immune thrombocytopenia

Investigational

Spain

Participants:0–17 years
Substances:Efgartigimod Alfa

Contact Research Centre

Congenital pseudarthrosis

Recruiting

InvestigationalNo placebo

Study of NVD003 stem cell implant compared to bone graft for children with congenital pseudarthrosis of the tibia

InvestigationalNo placebo

Spain

Participants:0–17 years
Substances:Autologous Adipose-Derived Stem Cells

Contact Research Centre

Find therapies in clinical trials near you – page 4

329 trials match your criteria

Major depression

A study testing intranasal esketamine compared to midazolam for rapidly reducing symptoms of major depressive disorder in adolescents with suicidal thoughts or behavior

Beta haemolytic streptococcal infection

A Study of Group B Streptococcus 6-Valent Polysaccharide Conjugate Vaccine in Healthy Pregnant Women and Their Infants

Still's disease

A Study of MAS825 in Children and Adults with Still's Disease to Test How Well It Works and How Safe It Is

Chronic graft versus host disease

Study of Axatilimab compared to standard therapy in children with chronic graft-versus-host disease who have previously received at least 2 treatments

Spinal muscular atrophy

Study of Apitegromab Treatment in Children Under 2 Years Old with Spinal Muscular Atrophy (SMA)

PIK3CA related overgrowth spectrum

Study of alpelisib in children and adults with PIK3CA-Related Overgrowth Spectrum (PROS)

Alopecia areata

Long-term safety and effectiveness study of ritlecitinib in children with severe alopecia areata who completed previous trials B7981027 or B7981031

Epileptic encephalopathy

Study of intrathecal S230815 to evaluate safety and effectiveness in children with KCNT1-related Developmental and Epileptic Encephalopathy

Chronic graft versus host disease

Study of belumosudil in children aged 1 to 18 years with moderate to severe chronic graft versus host disease requiring systemic treatment

B-cell lymphoma recurrent+1

Study of drug combination therapy in children and adolescents with relapsed or refractory B-cell non-Hodgkin lymphoma using odronextamab, loncastuximab tesirine and rituximab

Immune thrombocytopenia

Study of efgartigimod given by IV infusion in adolescents aged 12-17 years with chronic immune thrombocytopenia

Congenital pseudarthrosis

Study of NVD003 stem cell implant compared to bone graft for children with congenital pseudarthrosis of the tibia

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.